Opdivo is a human programed death receptor-1 (PD-1) blocking antibody indicated to treat this skin cancer. The indication is approved under accelerated approval based on tumor response rate
L-Bcl-2 is a liposomal encapsulated oligonucleotide targeted to the translation initiation site of human Bcl-2 mRNA. The antisense oligonucleotide in L-Bcl-2 is a nuclease-resistant, hydrophobic analog of phosphodiesters
Under the deal, Tekmira’s Ebola drug will be made available in West Africa for clinical trials which are expected to start in early 2015. Funded by the Wellcome
The company said that around 78 patients will be enrolled in the randomized, double-blind, placebo controlled Phase II trial that will be conducted in the US, Europe and
The drug will be indicated for ITP patients who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. ITP is characterized by a low platelet count and
Erwinaze is specified as an element of a multi-agent chemotherapeutic regimen to treat patients suffering from acute lymphoblasticleukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase. Jazz
Kalon is a biopharmaceutical contract manufacturing organization with advanced technologies and facilities. It is a key subcontractor to one of the three Centers for Innovation in Advanced Development
An agreement to this effect was signed between both the companies. As per the agreed terms, Cardinal Health will build a 64,000ft2 facility in Indianapolis for the production
With the acquisition, UPS will be able to strengthen its healthcare expertise and network in Europe and enable compliant logistics services to customers to help them stream their
Launched after the completion of the iv clinical development programme, posaconazole concentrate for solution for iv provides another option for treatment of fungal infections in critically ill patients
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.